公开(公告)号：US20170105988A1

公开(公告)日：2017-04-20

申请号：US15129365

申请日：2015-03-26

Applicant: UCB Biopharma SPRL

Inventor： Domenico Fanara ,  Jonathan Goole ,  Michel Deleers

IPC: A61K31/495 ,  A61K9/16 ,  A61K9/50 ,  A61K9/00

CPC classification number: A61K31/495 ,  A61K9/0053 ,  A61K9/0056 ,  A61K9/0095 ,  A61K9/1623 ,  A61K9/1652 ,  A61K9/1676 ,  A61K9/5036 ,  A61K9/5047

Abstract: The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.

公开(公告)号：US20190142759A1

公开(公告)日：2019-05-16

申请号：US16241184

申请日：2019-01-07

Applicant: UCB Biopharma SPRL

Inventor： Domenico Fanara ,  Frederic Eeckman ,  Monique Berwaer

IPC: A61K9/50 ,  A61K47/38 ,  A61K9/16 ,  C07D207/27 ,  A61K31/4015 ,  A61K47/32

Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

公开(公告)号：US20200297718A1

公开(公告)日：2020-09-24

申请号：US16750702

申请日：2020-01-23

Applicant: UCB Biopharma SPRL

Inventor： Domenico Fanara ,  Jonathan Goole ,  Michel Deleers

IPC: A61K31/495 ,  A61K9/16 ,  A61K9/00 ,  A61K9/50

Abstract: Disclosed are pharmaceutical compositions comprising levocetirizine.